Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0080
0.00 (0.00%)
Sep 8, 2026, 3:52 PM EST
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $940.96 thousand as of September 8, 2026. Its market cap has decreased by -16.52% in one year.
Market Cap
940.96K
Enterprise Value
60.15M
Revenue
18.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 940.96K, a decrease of -99.56%. That is a compound annual growth rate of -46.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.02M | -15.21% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AXIM Biotechnologies | 1.38M |
| Sirona Biochem | 1.35M |
| Abpro Holdings | 1.30M |
| Bio-Path Holdings | 1.29M |
| Helix BioMedix | 1.24M |
| Regenerative Medical Technology Group | 1.13M |
| Neon Bloom | 955.17K |
| CERo Therapeutics Holdings | 835.13K |